Turn Share Price

Turn Share Price

NASDAQ: TTRX | Micro Cap | Healthcare
$8.65
-$0.37 (-4.1%) Last updated on 20 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Turn Stock Performance

Open
$8.81
Prev. Close
$9.02
Circuit Range
N/A
Day Range
$8.58 - $9.03
Year Range
$2.64 - $16.29
Volume
1,739
Average Traded
$8.76

Turn Share Price Today

As of 20 November 2026, Turn Therapeutics Inc.'s share price is $8.65. The stock opened at $8.81, compared to its previous close of $9.02. During today's trading session, Turn Therapeutics Inc.'s share price traded between $8.58 and $9.03, with an average price of $8.80. Over the past 52 weeks, the stock has recorded a high of $16.29 and a low of $2.64. In terms of performance, Turn Therapeutics Inc.'s share price has risen by 73.17% over the last six months and is up 147.14% on a year-on-year basis.

Turn Share Price Chart

Line chart of the Turn price trend over the selected period. The price fell overall, ranging from 8.77 to 9.36, ending at 8.95.
$8.58$9.03
L
Show Current Price
H

Turn Stock Fundamentals & Key Indicators

Market Cap
$239.74M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.42
Revenue (TTM)
$0.00
Return On Equity (TTM)
-224.39%
Profit Margin
N/A
Debt to Equity
1.09
Quarterly Earnings Growth YoY
-2325.00%

Turn Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit$0.28-$0.97-$5.85-$6.23
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-446.43%-503.09%-6.50%

Turn Annual Profit & Loss

All figures in USD

Particulars2025
Revenue$0.00
Net Profit-$3.19
Net Profit MarginN/A
Income ChangeN/A

Turn Balance Sheet

All figures in USD Million

Particulars2025
Non Current Assets6.97
Current Assets5.2
Total Assets12.16
Non Current Liabilities1.47
Current Liabilities6.0
Total Liabilities7.48
Shareholders' Equity4.69

Turn Cash Flow

Annually

All figures in USD Million

Particulars2025
Operating-2.56
Investing-0.15
Financing6.92

About Turn

Turn Therapeutics Inc is a clinical-stage biotechnology and medical device development company built around its proprietary platform technology called PermaFusion designed to enhance drug performance. The company is developing non-systemic, non-biologic topical immunomodulators for inflammatory skin disease. Its program, GX-03, is being studied for moderate-to-severe eczema based on preclinical evidence of cytokine inhibition and reduced eczema severity, as well as a favorable real-world tolerability record from prior cleared medical device indications for the same formula. GX-03 is currently being evaluated in an ongoing, randomized, double-blind, vehicle-controlled clinical study designed to assess its potential as a topical treatment for moderate-to-severe eczema.

Turn Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$10.14
$8.58
-17.89%
Oct 2026
$13.39
$10.45
-27.13%
Sep 2026
$9.61
$14.34
+40.59%
Aug 2026
$8.46
$10.20
+22.01%
Jul 2026
$7.21
$8.36
+14.84%
Jun 2026
$5.87
$7.28
+45.75%
May 2026
$3.82
$5.00
+35.37%
Apr 2026
$3.10
$3.69
+17.89%
Mar 2026
$3.40
$3.13
-11.83%
Feb 2026
$4.17
$3.55
-14.25%
Jan 2026
$4.32
$4.14
+0.98%
Dec 2025
$3.64
$4.10
+17.14%

Turn Share Price FAQs